These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31795776)

  • 1. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review.
    Files J; Kling JM
    Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use.
    L'Hermite M
    Climacteric; 2017 Jun; 20(3):205-211. PubMed ID: 28509626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and benefit considerations for menopausal hormone therapy.
    Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS
    Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine bleeding with hormone therapies in menopausal women: a systematic review.
    Pickar JH; Archer DF; Goldstein SR; Kagan R; Bernick B; Mirkin S
    Climacteric; 2020 Dec; 23(6):550-558. PubMed ID: 32893694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
    Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery.
    Shufelt CL; Manson JE
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1245-1254. PubMed ID: 33506261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.
    Simon JA; Snabes MC
    Expert Opin Investig Drugs; 2007 Dec; 16(12):2005-20. PubMed ID: 18042008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS).
    Wild RA; Larson JC; Crandall CJ; Shadyab AH; Allison M; Gass M; Shufelt C; Manson JE
    Menopause; 2021 Jul; 28(10):1108-1116. PubMed ID: 34313617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging hormonal treatments for menopausal symptoms.
    Genazzani AR; Komm BS; Pickar JH
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioidentical hormone therapy: a review of the evidence.
    Cirigliano M
    J Womens Health (Larchmt); 2007 Jun; 16(5):600-31. PubMed ID: 17627398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patches.
    Newman MS; Saltiel D; Smeaton J; Stanczyk FZ
    Menopause; 2023 Nov; 30(11):1098-1105. PubMed ID: 37847876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.